Sperm quality is not affected by the BNT162b2 mRNA SARS-CoV-2 vaccine: results of a 6-14 months follow-up.

Gilad KaravaniHenry H ChillCherut MeirmanEinat Gutman-IdoShmuel HerzbergTachover TziporaTal ImbarAssaf Ben-Meir

Published in: Journal of assisted reproduction and genetics (2022)

The Pfizer-BioNTech (BNT162b2) SARS-CoV-2 vaccine does not impair any of the sperm parameters over a relatively long-time interval of 6 to 14 months from vaccination.

Keyphrases

sars cov
respiratory syndrome coronavirus
quality improvement